Tyler Paz Korman - 19 Aug 2026 Form 4/A - Amendment Insider Report for EXOZYMES INC. (EXOZ)

Reporting relationship: Chief Scientific Officer
Issuer ticker: EXOZ
Reported as of: 19 Aug 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 21 Oct 2026, 06:05:09 UTC
Original report date: 25 Aug 2026
Prior SEC filing: 10 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Tyler Korman

Filing notes and source

Key filing fact

Tyler Paz Korman filed Form 4/A - Amendment for EXOZYMES INC. (EXOZ) on 21 Oct 2026.

Key facts

This page summarizes Tyler Paz Korman's Form 4/A - Amendment filing for EXOZYMES INC. (EXOZ).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Oct 2026, 06:05.

Change

Previous filing in this sequence was filed on 10 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002032745 Primary reporting owner

Korman Tyler Paz

Relationship: Chief Scientific Officer
Address: 750 ROYAL OAKS DRIVE /106, MONROVIA
Signature: /s/ Tyler Korman
Signature date: 21 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXOZ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 729,123
Date: 19 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXOZ holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 79,104
Date: 19 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 79,104
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

The reporting person was granted an aggregate of 79,104 restricted stock units on March 28, 2022 and May 1, 2023, as reported on the Form 3 filed November 18, 2024. The units remain outstanding. No portion of the award has been settled.

SEC remarks

This Amendment is being filed to correct the Form 4 filed August 25, 2026 (Accession No. 0001493152-26-040116), which reported the conversion of 32,964 restricted stock units into 32,964 shares of common stock on August 19, 2026. That transaction was reported in error. The conversion did not occur and no shares were issued. Table I and Table II of this Amendment report the securities beneficially owned following removal of the reported transaction, and no transaction is reported.